Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIB NASDAQ:HEAL NASDAQ:IBBQ NASDAQ:LFSC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$56.75+1.1%$50.13$33.78▼$69.17$57.32M1.639,288 shs8,181 shsHEALGlobal X HealthTech ETF$10.67+2.2%$10.50$8.16▼$11.91$44.71M1.0924,261 shs7,147 shsIBBQInvesco Nasdaq Biotechnology ETF$23.76+0.9%$22.15$17.84▼$24.84$36.11M0.6112,535 shs5,282 shsLFSCF/m Emerald Life Sciences Innovation ETF$27.78+2.0%$25.23$18.78▼$27.85$64.16MN/A3,047 shs2,908 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology+0.85%+2.40%+9.74%+30.17%-16.60%HEALGlobal X HealthTech ETF+0.10%+0.87%-0.67%+2.25%+1,043,999,900.00%IBBQInvesco Nasdaq Biotechnology ETF+0.45%+1.29%+5.23%+15.27%-3.56%LFSCF/m Emerald Life Sciences Innovation ETF+0.69%+0.94%+10.11%+19.93%+2,728,499,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.66Moderate Buy$56.75N/AHEALGlobal X HealthTech ETF 2.63Moderate Buy$10.67N/AIBBQInvesco Nasdaq Biotechnology ETF 2.67Moderate Buy$23.76N/ALFSCF/m Emerald Life Sciences Innovation ETF 2.98Moderate Buy$27.78N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68∞N/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/A42.80∞N/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A17.03∞N/AN/AN/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.851.50%N/AN/AN/AHEALGlobal X HealthTech ETFN/A0.08%N/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.220.93%N/AN/AN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/ALatest HEAL, IBBQ, BIB, and LFSC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/26/2025HEALGlobal X HealthTech ETF$0.00826/27/20256/27/20257/7/20256/24/2025BIBProShares Ultra Nasdaq BiotechnologyQuarterly$0.17061.49%6/25/20256/25/20257/1/20256/23/2025IBBQInvesco Nasdaq Biotechnology ETFQuarterly$0.02870.55%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/ALFSCF/m Emerald Life Sciences Innovation ETFN/AInsider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/ALFSCF/m Emerald Life Sciences Innovation ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A1.01 millionN/AOptionableHEALGlobal X HealthTech ETFN/A4.19 millionN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/A1.52 millionN/AOptionableLFSCF/m Emerald Life Sciences Innovation ETFN/A2.31 millionN/AN/AHEAL, IBBQ, BIB, and LFSC HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to BuyBy Thomas Hughes | August 6, 2025Figma's Wild IPO Ride: Is the Stock's Premium Price Justified?By Jeffrey Neal Johnson | August 5, 2025Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNHBy Ryan Hasson | August 15, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025HEAL, IBBQ, BIB, and LFSC Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$56.75 +0.59 (+1.05%) Closing price 03:56 PM EasternExtended Trading$57.44 +0.69 (+1.22%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Global X HealthTech ETF NASDAQ:HEAL$10.67 +0.23 (+2.20%) As of 03:59 PM EasternAn ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ$23.76 +0.21 (+0.87%) Closing price 03:24 PM EasternExtended Trading$23.68 -0.07 (-0.30%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.F/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC$27.78 +0.55 (+2.00%) Closing price 03:19 PM EasternExtended Trading$27.78 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access